A detailed history of Fine Mark National Bank & Trust transactions in Abb Vie Inc. stock. As of the latest transaction made, Fine Mark National Bank & Trust holds 96,686 shares of ABBV stock, worth $17 Million. This represents 0.67% of its overall portfolio holdings.

Number of Shares
96,686
Previous 95,499 1.24%
Holding current value
$17 Million
Previous $16.4 Million 16.57%
% of portfolio
0.67%
Previous 0.61%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$163.84 - $199.33 $194,478 - $236,604
1,187 Added 1.24%
96,686 $19.1 Million
Q2 2024

Aug 02, 2024

BUY
$154.79 - $180.76 $249,676 - $291,565
1,613 Added 1.72%
95,499 $16.4 Million
Q1 2024

May 14, 2024

BUY
$159.82 - $182.1 $349,206 - $397,888
2,185 Added 2.38%
93,886 $17.1 Million
Q4 2023

Feb 09, 2024

SELL
$137.6 - $154.97 $290,886 - $327,606
-2,114 Reduced 2.25%
91,701 $14.2 Million
Q3 2023

Nov 15, 2023

BUY
$133.59 - $154.65 $1.55 Million - $1.8 Million
11,620 Added 14.14%
93,815 $14 Million
Q2 2023

Aug 11, 2023

BUY
$132.51 - $164.9 $607,425 - $755,901
4,584 Added 5.91%
82,195 $11.1 Million
Q1 2023

May 08, 2023

BUY
$144.61 - $166.54 $4.77 Million - $5.49 Million
32,990 Added 73.93%
77,611 $12.4 Million
Q4 2022

Feb 09, 2023

SELL
$138.31 - $165.87 $6,085 - $7,298
-44 Reduced 0.1%
44,621 $7.22 Million
Q3 2022

Nov 14, 2022

BUY
$134.21 - $153.93 $26,305 - $30,170
196 Added 0.44%
44,665 $5.99 Million
Q2 2022

Aug 09, 2022

SELL
$137.62 - $174.96 $126,610 - $160,963
-920 Reduced 2.03%
44,469 $6.81 Million
Q1 2022

May 16, 2022

SELL
$131.98 - $163.75 $65,858 - $81,711
-499 Reduced 1.09%
45,389 $7.36 Million
Q4 2021

Feb 14, 2022

SELL
$107.43 - $135.93 $101,091 - $127,910
-941 Reduced 2.01%
45,888 $6.21 Million
Q3 2021

Nov 12, 2021

BUY
$106.4 - $120.78 $294,408 - $334,198
2,767 Added 6.28%
46,829 $5.05 Million
Q2 2021

Aug 13, 2021

SELL
$105.21 - $117.21 $115,204 - $128,344
-1,095 Reduced 2.42%
44,062 $4.96 Million
Q1 2021

May 12, 2021

BUY
$102.3 - $112.62 $154,166 - $169,718
1,507 Added 3.45%
45,157 $4.89 Million
Q4 2020

Feb 10, 2021

BUY
$80.49 - $108.67 $249,358 - $336,659
3,098 Added 7.64%
43,650 $4.68 Million
Q3 2020

Nov 12, 2020

BUY
$85.91 - $100.83 $76,631 - $89,940
892 Added 2.25%
40,552 $3.55 Million
Q2 2020

Aug 13, 2020

BUY
$73.37 - $98.18 $28,174 - $37,701
384 Added 0.98%
39,660 $3.89 Million
Q1 2020

May 06, 2020

BUY
$64.5 - $97.79 $32,637 - $49,481
506 Added 1.31%
39,276 $2.99 Million
Q4 2019

Feb 07, 2020

SELL
$72.13 - $90.25 $50,563 - $63,265
-701 Reduced 1.78%
38,770 $3.43 Million
Q3 2019

Nov 08, 2019

BUY
$62.98 - $75.72 $60,019 - $72,161
953 Added 2.47%
39,471 $2.99 Million
Q2 2019

Aug 08, 2019

BUY
$65.7 - $83.98 $462,330 - $590,967
7,037 Added 22.35%
38,518 $2.8 Million
Q1 2019

May 07, 2019

SELL
$77.14 - $90.79 $468,008 - $550,822
-6,067 Reduced 16.16%
31,481 $2.54 Million
Q4 2018

Feb 07, 2019

SELL
$77.85 - $96.01 $135,459 - $167,057
-1,740 Reduced 4.43%
37,548 $3.46 Million
Q3 2018

Nov 02, 2018

SELL
$88.91 - $98.84 $5.77 Million - $6.41 Million
-64,901 Reduced 62.29%
39,288 $3.72 Million
Q2 2018

Aug 03, 2018

BUY
$89.78 - $106.23 $987 - $1,168
11 Added 0.01%
104,189 $9.65 Million
Q1 2018

Apr 26, 2018

SELL
$92.01 - $123.21 $160,649 - $215,124
-1,746 Reduced 1.65%
104,178 $9.86 Million
Q4 2017

Jan 30, 2018

SELL
$89.56 - $98.21 $400,601 - $439,293
-4,473 Reduced 4.05%
105,924 $10.2 Million
Q3 2017

Oct 30, 2017

BUY
$69.85 - $89.22 $7.71 Million - $9.85 Million
110,397
110,397 $9.81 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $310B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Fine Mark National Bank & Trust Portfolio

Follow Fine Mark National Bank & Trust and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fine Mark National Bank & Trust, based on Form 13F filings with the SEC.

News

Stay updated on Fine Mark National Bank & Trust with notifications on news.